Sanders Won’t Let Facts Get In Way of a Good Pharma Shaming


Vermont Senator Bernie Sanders called the CEOs of several major pharmaceutical firms to testify earlier this month before the Senate Health, Education, Labor and Pensions Committee, where he serves as chairman.

The hearing’s official purpose was to discuss prescription drug pricing. But it mainly offered Sanders a forum to castigate the pharmaceutical industry.

“The overwhelming beneficiary of high drug prices in America is the pharmaceutical industry,” Sanders said. “The United States government does not regulate drug companies. With a few exceptions, the drug companies regulate the United States government.”

Click to read the full article in Newsmax.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top